Educational

Gradient vs Isocratic HPLC, Explained for Peptides

Whether the mobile phase stays constant (isocratic) or changes during the run (gradient) changes what a peptide chromatogram looks like — and what it can prove. Here is the difference and why peptide purity testing almost always uses a gradient.

Published 2026-06-14Updated 2026-06-147 min readBy Mootez Chachia

Two peptide chromatograms can look completely different not because the peptides differ, but because the labs ran different elution modes. The single biggest method choice behind any peptide HPLC trace is whether the mobile phase stays constant throughout the run — isocratic — or changes during it — gradient. The choice shapes peak sharpness, how impurities show up, and what the chromatogram can honestly prove.

This guide explains the two modes in plain terms, why peptide purity testing almost always runs a gradient, and how to spot which one was used when you are scrutinizing a Certificate of Analysis. It assumes the basic picture from What Is HPLC? — the column, the pump, the detector — and zooms in on what the pump is actually doing with the solvent.

For laboratory research use only. Not for human consumption.

The mobile phase is the variable

In reversed-phase HPLC, the column is packed with a non-polar material and the mobile phase is a mix of water and an organic solvent such as acetonitrile. A molecule's retention depends on a tug-of-war: it sticks to the non-polar column, and the organic solvent competes to pull it back into the flow. The more organic solvent in the mobile phase, the more "eluting strength" it has, and the faster compounds come off the column.

That gives the analyst a lever. Hold the solvent mixture constant, and every compound experiences the same eluting strength for the entire run. Change the mixture over time — usually ramping the organic fraction up — and eluting strength increases as the run proceeds. Those two choices are isocratic and gradient elution.

Isocratic: one mixture, start to finish

Isocratic elution uses a single, fixed mobile phase composition for the whole run. The pump delivers, say, 30% acetonitrile and 70% acidified water from the first second to the last. It is the simpler mode: fewer variables, easier to reproduce on another instrument, and no time needed to re-equilibrate the column between runs.

The limitation shows up with mixtures that span a wide range of retention strengths. Pick a composition strong enough to elute a sticky impurity in reasonable time, and weakly retained components rush out at the front in a cluster. Pick a composition gentle enough to separate the early-eluting components, and strongly retained impurities crawl off late as broad, flat, hard-to-integrate humps — or never fully elute, carrying over to contaminate the next injection. Isocratic peaks also broaden the later they elute, so a late impurity may smear into the baseline and be undercounted.

For a single, clean, well-characterized compound with a narrow retention range, a validated isocratic method can be entirely adequate. For surveying everything in a synthesis vial, it is often the wrong tool.

Gradient: changing strength across the run

Gradient elution changes the mobile phase composition during the run, almost always by increasing the organic solvent over time. A peptide method might start near 5% acetonitrile and ramp toward 60% or more across 20 to 30 minutes, then briefly hold high before returning to the starting composition to re-equilibrate.

The effect is that eluting strength rises continuously. Weakly retained components come off early, while the strength is still low, so they separate instead of bunching at the front. Strongly retained components stay put until the rising organic fraction finally overcomes their grip, then come off as sharp peaks rather than broad humps. The practical result is that a gradient can resolve a much wider range of compounds in one run, with peaks that stay narrow across the whole chromatogram.

Why this matters for purity

Purity profiling is precisely the wide-range problem gradients are built for. A peptide vial holds the target plus synthesis byproducts and degradation fragments spanning a broad hydrophobicity range. A gradient walks through that entire range and pulls each component off in turn — which is why it surfaces impurities an isocratic method might leave stuck on the column or buried in a late, flat baseline.

Why peptide purity COAs almost always use a gradient

Peptide synthesis is never perfectly clean. A real sample contains the target peptide alongside truncated sequences, deletion products, and oxidation or deamidation fragments — molecules that can be far more or far less hydrophobic than the target. A purity method's job is to surface all of them so the integration honestly reflects what is in the vial.

A gradient is the natural fit. By scanning eluting strength from low to high, it gives every impurity class a chance to separate and register as its own peak. That is why the chromatograms behind legitimate peptide purity numbers — the ones in our annual purity work and on credible suppliers' COAs — are overwhelmingly gradient runs. An isocratic method tuned to make the target peak look clean while strongly retained impurities never elute would understate impurity content. That failure mode is one more reason the method section of a COA matters as much as the headline number.

How to tell which mode was used

When you are reading a chromatogram, a few tells help you infer the elution mode:

  • Baseline behavior. Gradient runs often show a gently rising or drifting baseline, because the changing solvent composition alters background UV absorbance through the run. A modest, smooth drift is normal for a gradient — not a sign of manipulation. Isocratic runs tend to show a flatter baseline.
  • Peak width across the run. In gradient mode, peaks stay roughly narrow whether they elute early or late. In isocratic mode, later-eluting peaks visibly broaden. A chromatogram where a late peak is sharp despite a long run time was probably run as a gradient.
  • The stated method. Most decisive of all: a proper COA states the elution program. A gradient method lists the starting and ending composition and the time course; an isocratic method names the fixed composition. If the method section is blank, you cannot reproduce the result regardless of mode — see our chromatogram reading guide for the full verification checklist.

Bottom line

Isocratic means one mobile phase composition for the whole run; gradient means the composition changes, usually ramping the organic solvent up to scan eluting strength from low to high. Isocratic is simpler and fine for a single well-behaved compound. Gradient is the standard for peptide purity testing because synthesis samples span a wide hydrophobicity range, and only a gradient reliably pulls every impurity off the column where it can be seen and counted.

When you evaluate a COA, look for a stated gradient program, a smoothly drifting baseline consistent with one, and sharp peaks across the run. Those are the marks of a method built to find impurities rather than hide them. For the compound profiles these methods test, browse the peptides catalog and the research hub, and pair this with why detection happens at 220nm.

For research use only. Not for human consumption.

2026 Evaluation
9.6/10
Top-Ranked 2026 Supplier

The top-ranked supplier in our 2026 evaluation

ROEHN Research tested at 99.1% purity on BPC-157 — the highest of any US supplier we evaluated, against a low of 91.3%. Readers save 15% on a first order with code FREE15.

View ROEHN Research
Save 15% with code FREE15
  • Cold-chain shipped
  • Batch CoA in every box
  • 30-day re-test policy
  • 98%+ verified purity

Related reading:

The Report

Get the full 38-sample purity report by email.

Eight US suppliers, thirty-eight samples, one blinded analytical lab. Every chromatogram, COA, and supplier score — delivered the moment you subscribe.

PDF delivered instantly. No account required. Unsubscribe anytime.